Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2008
12/16/2008US7465549 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein
12/16/2008US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases
12/16/2008US7465547 sandwich method, are able to quantitatively or qualitatively determine human low-molecular-weight CD14 with high sensitivity and specificity in a simple manner, so that they are useful for the diagnosis of a patient suffering from sepsis
12/16/2008US7465540 Detecting binding positions on preferential particles; obtain microspheres, incubate with reaction mixtures, detect bound particles, record positions
12/16/2008US7465538 Multiplex flow assays preferably with magnetic particles as solid phase
12/16/2008US7465536 solid support member; a specific indicator immobilized on the solid support member; and a retaining member which holds the solid support, the retaining member and solid support are configured so that the solid support will readily contact a surface being tested for the presence of biological soil
12/16/2008US7465451 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
12/16/2008US7465449 Anti-αvβ6 antibodies
12/16/2008US7465448 Chemokine receptor antagonists as therapeutic agents
12/16/2008US7465446 Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease
12/16/2008US7465427 Apparatus, system, and method of detecting an analyte utilizing pyroelectric technology
12/16/2008US7465426 comprises a tank, feeders, extractors, analyzer; extractors comprise an ultrasonic electroacoustic transducer and the mud feeders comprise volume and flow rate regulators that enable a preset constant volume of mud to be guaranteed in the tank and the flow rate to be adjusted to a preset constant value
12/16/2008US7465425 Apparatus identifies an analyte by comparing a single pattern of alternating current electrical information of the analyte at various selected frequencies ranging from 10 KHz to 1 MHz with patterns of electrical information of known analytes; portable; fewer interference deficiency, enhanced sensitivity
12/16/2008US7465342 preselecting said dye such that it includes at least one moiety for reducing intermolecular interactions; invisible ink
12/16/2008US7465276 Identification of disease characteristics using isotope ratios in breath
12/16/2008US7465275 Method and apparatus for measuring functional residual capacity (FRC) and cardiac output(CO)
12/16/2008US7464531 Method for visually displaying the maintaining of specified effects
12/16/2008CA2585695C Disposable immunodiagnostic test system
12/16/2008CA2527742C Determination of contaminant particles in an aqueous pulp
12/16/2008CA2449071C Chimaeric phages
12/16/2008CA2413978C Multianalyte molecular analysis
12/16/2008CA2321739C Random access slide stainer with liquid waste segregation
12/16/2008CA2268099C Screening methods for glucocorticoid receptor binding substances using tripterygium wilfordii preparations
12/16/2008CA2253632C Compositions and methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
12/16/2008CA2249173C Diagnostic agent for liver function
12/16/2008CA2239692C Diagnosis and treatment of aur-1 and/or aur-2 related disorders
12/16/2008CA2215198C Assay devices
12/16/2008CA2195753C Determination of a specific immunoglobulin using multiple antigens
12/16/2008CA2177554C Reduction in first slide bias and improved enzyme stability by the incorporation of diaryl tellurides in thin-film immunoassay elements
12/11/2008WO2008151303A1 Long wavelength fluorogenic intercellular ion indicators
12/11/2008WO2008151258A2 O-linked glycosylation using n-acetylglucosaminyl transferases
12/11/2008WO2008151238A1 Biomarkers for prostate cancer
12/11/2008WO2008151207A2 Expression quantification using mass spectrometry
12/11/2008WO2008151146A2 Peptide arrays and methods of use
12/11/2008WO2008151127A1 Compounds and methods for chemical ligation
12/11/2008WO2008151110A2 Molecular diagnosis and typing of lung cancer variants
12/11/2008WO2008151055A1 Diagnosing neurodegenerative diseases
12/11/2008WO2008150964A1 Methods and kits for diagnosing and treating acute joint injury
12/11/2008WO2008150873A1 Ultrasensitive detection of biomolecules using immunoseparation and diffractometry
12/11/2008WO2008150870A1 Methods of employing vascular leakage to diagnose a capillary leak disorder
12/11/2008WO2008150845A1 Screening for wnt pathway modulators and pyrvinium for the treatment of cance
12/11/2008WO2008150835A1 Particle fraction determination of a sample
12/11/2008WO2008150832A1 Assay methods for identifying agents that modify the activity of nape-pld or abh4
12/11/2008WO2008150496A2 Assay for sensitivity to chemotherapeutic agents
12/11/2008WO2008150491A2 BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFα INHIBITORS IN AUTOIMMUNE DISORDERS
12/11/2008WO2008150490A2 Uses and compositions for treatment of psoriasis and crohn's disease
12/11/2008WO2008150488A1 Methods and systems for quantification of peptides and other analytes
12/11/2008WO2008150467A1 Screening assays for inhibitors of beta amyloid peptide ion channel formation
12/11/2008WO2008150436A1 Analyte determination methods and devices
12/11/2008WO2008150292A1 Method and device for obtaining uniform samples of meat
12/11/2008WO2008150261A1 Detection and quantitation of calicheamicin
12/11/2008WO2008150158A1 Novel plant virus designated tomato marchitez virus
12/11/2008WO2008150096A1 Measuring equipment for quality of water
12/11/2008WO2008150091A2 Novel analytical method for protein
12/11/2008WO2008150025A1 Novel bone mass increasing agent
12/11/2008WO2008149976A1 Cardiac reentry model chip and apparatus and method for evaluating drug using the cardiac reentry model chip
12/11/2008WO2008149809A1 Cell chip for evaluation of cellular motility
12/11/2008WO2008149807A1 Method for induction of differentiation of es cell
12/11/2008WO2008149803A1 Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers
12/11/2008WO2008149782A1 Prognostic factor in sarcoma, and metastasis inhibitor
12/11/2008WO2008149526A1 Novel sugar-chain-modified haptoglobin
12/11/2008WO2008149365A2 Systems and methods for focusing particles
12/11/2008WO2008149364A2 Methods for diagnosing hypersensitivity reactions
12/11/2008WO2008149247A2 Kinetic determination of peracid and/or peroxide concentrations
12/11/2008WO2008149124A2 Apparatus for determining the concentration of a conductive fluid present in a fluid filled borehole
12/11/2008WO2008149088A2 Melanoma assay and antigens
12/11/2008WO2008149055A1 Automatic characterization of cellular motion
12/11/2008WO2008148987A2 Process for detecting gaseous halogenated compounds
12/11/2008WO2008148890A1 Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
12/11/2008WO2008148886A1 Multiple analysis of blood samples
12/11/2008WO2008148884A1 Compositions and methods for treating pancreatic tumors
12/11/2008WO2008148883A1 Multiplex method for detecting an infection
12/11/2008WO2008148881A1 The puro-dhfr quadrifunctional marker and its use in protein production
12/11/2008WO2008148860A1 New neuronal viability factor and use thereof
12/11/2008WO2008148858A1 The novel adipocytokine visfatin/pbef1 is an apoptosis associated factor induced in monocytes during in vivo hiv-1 infection
12/11/2008WO2008148857A1 Method for assessing the risk of a cardiovascular disease and for diagnosing dyslipidemia
12/11/2008WO2008148723A1 Hydrophilic coating paint
12/11/2008WO2008148671A1 Hcv ns3 replicon shuttle vectors
12/11/2008WO2008148653A1 Fluid sensor device
12/11/2008WO2008148645A1 Separation of mono- from multi-phoshorylated peptides
12/11/2008WO2008148596A1 Method and device for measuring at least one quality variable, e.g. the moisture or basis weight, of a fiber web, especially a paper web, by determining the resonant frequency and the line width of a microwave resonator, e.g. a planar ring resonator, that is influenced by the fiber web
12/11/2008WO2008148582A1 Use of fibroblast growth factor 7 (fgf7) and of the receptor fgfr2b as biomarkers
12/11/2008WO2008148547A1 Detection of an analyte in a sample of hemolyzed whole blood
12/11/2008WO2008148522A2 Method to identify modulators of b-raf protein kinase and their use for the treatment of anxiety and depression
12/11/2008WO2008148493A2 Annexin a5 and annexin a6 as biomarkter for alzheimer's disease
12/11/2008WO2008148492A1 Neurofilamental proteins as biomarker for alzheimer's disease
12/11/2008WO2008148491A1 Neural cell adhesion molecule 1 as biomarker for alzheimer's disease
12/11/2008WO2008148490A1 Hsp27 as biomarker for alzheimer's disease
12/11/2008WO2008148489A1 Neurochondrin-1 as biomarker for alzheimer's disease
12/11/2008WO2008148488A1 Tubulin b6 as biomarker for alzheimer's disease
12/11/2008WO2008148463A1 Splice-variants of g-protein coupled receptor ep3 and uses thereof
12/11/2008WO2008148308A1 Urinoscopy reagent for detecting breast malignant disease and its application
12/11/2008WO2008148216A1 Drak2 expression is associated with diabetes
12/11/2008WO2008148193A1 Fhl1 mutations associated with novel x-linked muscular myopathies
12/11/2008WO2008148161A1 In situ methods for gene mapping and haplotyping
12/11/2008WO2008148143A1 Diagnostics in a monoplex/multiplex format
12/11/2008WO2008131382A3 Drop-on-demand manufacturing of diagnostic test strips
12/11/2008WO2008129296A3 Disease markers
12/11/2008WO2008128029A3 Solution fragmentation systems and processes for proteomics analysis
12/11/2008WO2008125957A3 Method for identification and relative quantification of cellular proteins